Gradient line
Gradient line
button Home button Co-organizers button Partners button Program button Registration
Gradient line
button download pdf document of the final program

2010 Final Program

8:30

Welcoming Address

8:35

Research, Innovation and Partnership
France Dionne, Québec Government Representative
Québec Government Office in Boston


Technology Presentations - Diagnostic Applications and Anti-infectives

8:50 Diagnostic for Transplantation: Graft vs Host Disease and Renal Transplantation
Anne-Marie Larose, pdf iconUnivalor (VAL-652), video iconVideo Presentation
9:00 First in Class 5-OXO-ETE Receptor Antagonists
Michèle Beaulieu, pdf iconMcGill (09044), video iconVideo Presentation
9:10 Gene Signatures to Identify Cirrhosis Patients at Risk for Liver Cancer and Predict Cancer Recurrence
Rahul Ballal, pdf iconMTTC-Broad, video iconVideo Presentation
9:20 Cancer Prognostic Markers and the Method for Finding Them
Edwin Wang, pdf iconNRC-BRI (12020), video iconVideo Presentation
9:30 A Chemistry Platform for Gene Silencing: Antisense and siRNA
Masad Damha, pdf iconMcGill (09065), video iconVideo Presentation
9:40 Novel H1V-1 Protease Inhibitors
Celia A. Schiffer, pdf iconMTTC - UMassMed, video iconVideo Presentation
9:50 Multi-Modal Imaging Agents for Molecular Diagnosis of Cancer
Stacey Nunes, pdf iconNRC-IBS (12075), video iconVideo Presentation
10:00 Novel HSV2 Vaccine Technology
Feng Yao, pdf iconMTTC-Brigham, video iconVideo Presentation
10:10 Morning Coffee Break


Technology Presentations - CNS, Ophthalmology and Gene Therapy

10:30 Lodamin: A Novel Oral Drug for Oncology, Ophthalmology and Autoimmune Diseases
Ofra Benny-Ratsaby, pdf iconMTTC-Children’s, video iconVideo Presentation
10:40 Novel Peptide(s) for the Treatment of Alzheimer’s Disease
Stacey Nunes, pdf iconNRC-IBS (11630), video iconVideo Presentation
10:50 Trk Family Receptor Ligands for Treatment of Neurodegenerative Diseases
Uri Saragovi, pdf iconMcGill (10051), video iconVideo Presentation
11:00 New Targets for Inflammatory Disease of the Nervous System Including Multiple Sclerosis
Anne-Marie Larose, pdf iconUnivalor (VAL-737), video iconVideo Presentation
11:10 Bacterial Components for Allergic Airway Disorder Therapy
Yves Geoffrion, pdf iconNRC-IBS (11894), video iconVideo Presentation
11:20 New Target and Compounds for Treating Age-Related Macular Degeneration
Louis Provencher, pdf iconUnivalor (VAL-620), video iconVideo Presentation
11:30 Muscle-Mediated Gene Therapy
Rénald Gilbert, pdf iconNRC-BRI (11887), video iconVideo Presentation
11:40 Atoxic Recombinant Holotoxins of Clostridium Difficile as Immunogens
Feng Hanping , pdf iconMTTC - Tufts University, video iconVideo Presentation
11:50 U.S. Venture Capital Investing in Canadian Life Science Companies - Challenges and Opportunities
Leonard M. Gold, Partner, Chair of Canada Practice
Burns & Levinson LLP
Dr. Ronda P. Moore, Partner, Intellectual Property/SciTech Group
Burns & Levinson LLP
12:10 Lunch and Networking


Technology Presentations - Technology Platforms

13:10 HEK293 Cell Line for Industrial Production of Recombinant Proteins, Viral Vectors and Vaccines
Bernard Massie, pdf iconNRC-BRI (10894), video iconVideo Presentation
13:20 A New Platform for Generating Optimized Peptides Library
Anne-Marie Larose, pdf iconUnivalor (VAL-708), video iconVideo Presentation
13:30 Vaccine Adjuvant Platform
Olivia Novac, pdf iconMcGill (10084), video iconVideo Presentation
13:40 Human Soluble VH and VL Single-Domain Antibody Libraries for Human Therapeutic Applications
Jamshid Tanha, pdf iconNRC-IBS (11686), video iconVideo Presentation
13:50 Platform Technology for Small Molecule Modulators of Autophagy
Junying Yuan, pdf iconMTTC-Harvard, video iconVideo Presentation
14:00 Cumate-Inducible Expression System in Eukaryotic Cells
Benard Massie, pdf iconNRC-BRI (11648), video iconVideo Presentation
14:10 A New Vaccine Platform to Ensure Epitope Delivery for both MHC Presentation (e.g. Hepatitis C Novel Antigen)
Louis Provencher, pdf iconUnivalor (VAL-678), video iconVideo Presentation
14:20 Synthetic Ether Lipid (Archaeosome) Delivery/Adjuvant Technology
Yves Geoffrion, pdf iconNRC-IBS (11784), video iconVideo Presentation
14:30 Efficient, Fast and Productive Method for Large-Scale Transfection of CHO and HEK293 Cells
Yves Durocher, pdf iconNRC-BRI (11992), video iconVideo Presentation
14:40 Engineered Biosynthetic Pathway for Sialic Acid Analogs and its Use for the Development of Anti-Infectives
Ian Schoenhofen, pdf iconNRC-IBS (12033), video iconVideo Presentation
14:50 Afternoon Coffee Break


Technology Presentations - Oncology and Transplantation

15:10 Chemosensitizing Agents for Multidrug Resistance (MDR) & Chemotherapy
Larry Chow, pdf iconMcGill (09086), video iconVideo Presentation
15:20 TGF-β Biologic Targeted Therapy for Oncology, Cardiovascular Disease and Nephrology Indications
Maureen O’Connor, pdf iconNRC-BRI (11817), video iconVideo Presentation
15:30 Use of Novel Proteasome Inhibitors to Treat Cancer and Disorders in the Immune System
Clermont Beaulieu, pdf iconUnivalor (VAL-789), video iconVideo Presentation
15:40 Novel Peptide(s) for the Treatment of Cancer
Danica Stanimirovic, pdf iconNRC-IBS (11627), video iconVideo Presentation
15:50 A Simple, Scalable and High Yield Method for High Level Production of Human Recombinant Interferon
Yves Durocher, pdf iconNRC-BRI (11993), video iconVideo Presentation
16:00 Fusion Protein Platform: Anti-Cancer, Anti-Inflammatory and Immunosuppressive
Jacques Galipeau, pdf iconMcGill (06087), video iconVideo Presentation
16:10 Antimetabolites C3’
Louis Provencher, pdf iconUnivalor (VAL-740), video iconVideo Presentation
16:20 Novel Anti-Mitotic Peptides for the Treatment of Cancer
Giovanna Sebastiani, pdf iconMcGill (04086), video iconVideo Presentation
16:30 Expansion of Hematopoeitic Stem Cells
Carla DeMaria, pdf iconMTTC-Whitehead, video iconVideo Presentation
16:40
Title of the Presentation to be Confirmed
Philip McGurk, Senior Director, Worldwide Business Development
Pfizer Inc.
17:00 Cocktail
blank spaceFooter Line
 
Date Modified: 2010-06-17
Top of page